Advances in Nanotechnology for Biofilm Inhibition.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
20 Jun 2023
20 Jun 2023
Historique:
received:
03
04
2023
accepted:
23
05
2023
medline:
26
6
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
Biofilm-associated infections have emerged as a significant public health challenge due to their persistent nature and increased resistance to conventional treatment methods. The indiscriminate usage of antibiotics has made us susceptible to a range of multidrug-resistant pathogens. These pathogens show reduced susceptibility to antibiotics and increased intracellular survival. However, current methods for treating biofilms, such as smart materials and targeted drug delivery systems, have not been found effective in preventing biofilm formation. To address this challenge, nanotechnology has provided innovative solutions for preventing and treating biofilm formation by clinically relevant pathogens. Recent advances in nanotechnological strategies, including metallic nanoparticles, functionalized metallic nanoparticles, dendrimers, polymeric nanoparticles, cyclodextrin-based delivery, solid lipid nanoparticles, polymer drug conjugates, and liposomes, may provide valuable technological solutions against infectious diseases. Therefore, it is imperative to conduct a comprehensive review to summarize the recent advancements and limitations of advanced nanotechnologies. The present Review encompasses a summary of infectious agents, the mechanisms that lead to biofilm formation, and the impact of pathogens on human health. In a nutshell, this Review offers a comprehensive survey of the advanced nanotechnological solutions for managing infections. A detailed presentation has been made as to how these strategies may improve biofilm control and prevent infections. The key objective of this Review is to summarize the mechanisms, applications, and prospects of advanced nanotechnologies to provide a better understanding of their impact on biofilm formation by clinically relevant pathogens.
Identifiants
pubmed: 37360468
doi: 10.1021/acsomega.3c02239
pmc: PMC10286099
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
21391-21409Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Saudi J Biol Sci. 2021 Mar;28(3):1615-1621
pubmed: 33732047
Microb Pathog. 2022 Apr;165:105461
pubmed: 35240288
Biomaterials. 2022 Jul;286:121597
pubmed: 35688112
Polymers (Basel). 2022 Jan 18;14(3):
pubmed: 35160348
Pharmaceutics. 2021 Mar 02;13(3):
pubmed: 33801281
Food Res Int. 2022 Jun;156:111160
pubmed: 35651026
Biotechnol Appl Biochem. 2022 Apr;69(2):714-725
pubmed: 33751641
Proc Natl Acad Sci U S A. 2022 Mar 22;119(12):e2113723119
pubmed: 35290120
Cytokine. 2023 Mar;163:156135
pubmed: 36724716
J Mater Chem B. 2021 Jun 3;9(21):4390-4399
pubmed: 34018538
J Drug Target. 2019 Nov;27(9):995-1003
pubmed: 30741037
Nat Rev Chem. 2023 Jan;7(1):5-6
pubmed: 37117824
Int J Pharm. 2022 Jul 25;623:121863
pubmed: 35643347
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Jul;52(4):598-604
pubmed: 34323037
ACS Omega. 2022 Dec 29;8(1):10-41
pubmed: 36643475
Antibiotics (Basel). 2023 Jan 04;12(1):
pubmed: 36671287
Polymers (Basel). 2023 Feb 23;15(5):
pubmed: 36904364
Colloids Surf B Biointerfaces. 2021 Aug;204:111811
pubmed: 33965751
Biomolecules. 2021 Mar 09;11(3):
pubmed: 33803150
Adv Drug Deliv Rev. 2021 Jul;174:30-52
pubmed: 33845040
Front Microbiol. 2020 May 21;11:928
pubmed: 32508772
Adv Drug Deliv Rev. 2021 Nov;178:113973
pubmed: 34530014
Materials (Basel). 2021 Jul 07;14(14):
pubmed: 34300720
Braz J Microbiol. 2021 Dec;52(4):1701-1718
pubmed: 34558029
Int J Mol Sci. 2021 Feb 03;22(4):
pubmed: 33546487
Biomedicines. 2023 Feb 02;11(2):
pubmed: 36830971
J Control Release. 2023 Jan;353:350-365
pubmed: 36473605
Pathogens. 2022 Jan 07;11(1):
pubmed: 35056021
Pathogens. 2022 Feb 27;11(3):
pubmed: 35335624
Polymers (Basel). 2019 Oct 09;11(10):
pubmed: 31600969
ACS Appl Mater Interfaces. 2022 Jul 20;14(28):31525-31540
pubmed: 35790214
Antibiotics (Basel). 2023 Jan 17;12(2):
pubmed: 36830106
Antibiotics (Basel). 2022 May 16;11(5):
pubmed: 35625312
J Appl Microbiol. 2020 Jan;128(1):15-27
pubmed: 31102552
Annu Rev Microbiol. 2001;55:165-99
pubmed: 11544353
Pharmaceutics. 2022 Mar 15;14(3):
pubmed: 35336016
BMC Microbiol. 2014 Sep 30;14:253
pubmed: 25266973
ACS Nano. 2022 May 24;16(5):7961-7970
pubmed: 35504042
Biomater Sci. 2023 Mar 14;11(6):1994-2019
pubmed: 36748318
Adv Drug Deliv Rev. 2023 Jan;192:114634
pubmed: 36503884
Front Microbiol. 2022 Oct 03;13:939390
pubmed: 36262331
Nanomaterials (Basel). 2020 Feb 09;10(2):
pubmed: 32050443
Science. 2023 Feb 17;379(6633):eabp8964
pubmed: 36795835
Nano Converg. 2016;3(1):1
pubmed: 28191411
ACS Infect Dis. 2021 Aug 13;7(8):2352-2361
pubmed: 34339169
Nat Commun. 2020 Mar 13;11(1):1354
pubmed: 32170131
Braz J Microbiol. 2021 Jun;52(2):619-625
pubmed: 33619696
Front Cell Infect Microbiol. 2014 Jun 20;4:82
pubmed: 24999454
Nanomaterials (Basel). 2019 May 17;9(5):
pubmed: 31109013
Antimicrob Resist Infect Control. 2020 Oct 20;9(1):162
pubmed: 33081846
J Biol Chem. 1999 Dec 24;274(52):37169-76
pubmed: 10601279
Bioorg Chem. 2023 Jul;136:106551
pubmed: 37094480
Biomater Sci. 2022 Dec 20;11(1):62-75
pubmed: 36373563
Evid Based Complement Alternat Med. 2021 Oct 27;2021:1567017
pubmed: 34745275
J Control Release. 2020 Dec 10;328:251-262
pubmed: 32889053
J Med Microbiol. 2020 Mar;69(3):402-413
pubmed: 32223838
Future Med Chem. 2021 Dec;13(23):2033-2046
pubmed: 34612074
ACS Nano. 2012 Jun 26;6(6):5164-73
pubmed: 22587225
Microb Pathog. 2022 Dec;173(Pt A):105860
pubmed: 36341845
Int J Mol Sci. 2023 Feb 17;24(4):
pubmed: 36835442
Molecules. 2020 Jun 16;25(12):
pubmed: 32560208
Front Cell Dev Biol. 2014 Apr 01;2:11
pubmed: 25364719
Infect Immun. 2000 Jun;68(6):3305-13
pubmed: 10816478
Pharmaceutics. 2016 May 24;8(2):
pubmed: 27231933
Chemosphere. 2022 May;295:133827
pubmed: 35122818
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84
pubmed: 25280707
Int J Pharm. 2020 Sep 25;587:119646
pubmed: 32679261
Front Cell Infect Microbiol. 2022 May 11;12:877995
pubmed: 35646720
ACS Appl Mater Interfaces. 2020 Oct 14;12(41):46991-47001
pubmed: 32937073
Nat Rev Microbiol. 2004 Feb;2(2):95-108
pubmed: 15040259
Mater Horiz. 2023 Feb 6;10(2):361-392
pubmed: 36541078
Mar Drugs. 2019 Jan 10;17(1):
pubmed: 30634609
Drug Deliv Transl Res. 2021 Feb;11(1):305-317
pubmed: 32519201
Pharmaceutics. 2022 Jan 16;14(1):
pubmed: 35057099
Mikrochim Acta. 2021 Dec 14;189(1):27
pubmed: 34905090
Colloids Surf B Biointerfaces. 2014 Sep 1;121:92-8
pubmed: 24945607
mSystems. 2023 Feb 23;8(1):e0089722
pubmed: 36622157
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:939-947
pubmed: 27524096
Microorganisms. 2022 Jun 27;10(7):
pubmed: 35889016
Comput Struct Biotechnol J. 2019 Oct 25;17:1360-1366
pubmed: 31762959
Biomater Adv. 2022 Mar;134:112592
pubmed: 35527134
Int J Mol Sci. 2022 Feb 07;23(3):
pubmed: 35163794
Front Microbiol. 2020 Jul 10;11:1609
pubmed: 32754144
Trends Microbiol. 2019 Nov;27(11):915-926
pubmed: 31420126
J Appl Microbiol. 2021 Dec;131(6):2626-2639
pubmed: 33650748
Biofilm. 2022 Oct 22;4:100089
pubmed: 36324525
Front Cell Infect Microbiol. 2022 Oct 12;12:917038
pubmed: 36310876
Front Microbiol. 2017 Jun 16;8:1104
pubmed: 28670301
Pathogens. 2019 Apr 14;8(2):
pubmed: 31014001
J Pharm Sci. 1999 Dec;88(12):1254-8
pubmed: 10585219
Nanomaterials (Basel). 2021 May 10;11(5):
pubmed: 34068834
Polymers (Basel). 2021 Feb 09;13(4):
pubmed: 33572439
Polymers (Basel). 2022 Jul 26;14(15):
pubmed: 35893988
Pharmaceutics. 2021 Jan 14;13(1):
pubmed: 33466852
mBio. 2022 Oct 19;13(6):e0221222
pubmed: 36259726
Pathogens. 2019 Apr 24;8(2):
pubmed: 31022836
Microb Pathog. 2016 Apr;93:137-44
pubmed: 26853754
PLoS Pathog. 2008 Apr 25;4(4):e1000052
pubmed: 18437240
Pharmaceutics. 2022 Jul 31;14(8):
pubmed: 36015230
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
Molecules. 2021 Aug 16;26(16):
pubmed: 34443542
Antibiotics (Basel). 2022 Apr 08;11(4):
pubmed: 35453246
Indian J Microbiol. 2019 Mar;59(1):3-12
pubmed: 30728625
Trends Microbiol. 2022 Sep;30(9):841-852
pubmed: 35337697
J Bacteriol. 2022 Feb 15;204(2):e0049421
pubmed: 34871031
Pathog Dis. 2018 Dec 1;76(9):
pubmed: 30657912
Biomater Sci. 2020 Dec 7;8(23):6526-6532
pubmed: 33103167
Int J Nanomedicine. 2021 Dec 16;16:8121-8138
pubmed: 34938074
Nanoscale. 2022 Jul 7;14(26):9286-9296
pubmed: 35649277
J Nanosci Nanotechnol. 2014 Jul;14(7):4745-56
pubmed: 24757944
Antibiotics (Basel). 2022 Dec 15;11(12):
pubmed: 36551482
Carbohydr Polym. 2021 Jun 15;262:117939
pubmed: 33838816
J Control Release. 2022 Dec;352:460-471
pubmed: 36341930
Nanomaterials (Basel). 2019 Jan 02;9(1):
pubmed: 30609710
Microbiology (Reading). 2015 Jul;161(7):1369-77
pubmed: 25922418
Microbiol Spectr. 2015 Jun;3(3):
pubmed: 26185074
ACS Appl Mater Interfaces. 2022 Mar 2;14(8):10200-10211
pubmed: 35179370
Microb Biotechnol. 2022 Jun;15(6):1695-1718
pubmed: 34843159
Infect Dis Ther. 2022 Apr;11(2):661-682
pubmed: 35150435
Appl Environ Microbiol. 2023 Feb 28;89(2):e0193222
pubmed: 36700647
J Biol Chem. 2018 Aug 31;293(35):13377-13388
pubmed: 30002121
Bioact Mater. 2023 Jan 02;24:401-437
pubmed: 36632508
Arch Microbiol. 2023 Jan 11;205(2):62
pubmed: 36629918
Int J Pharm. 2021 Nov 20;609:121163
pubmed: 34624448
Int J Biol Sci. 2021 Aug 18;17(13):3573-3582
pubmed: 34512166
Microorganisms. 2023 Jan 14;11(1):
pubmed: 36677505
Biofilm. 2022 Mar 19;4:100074
pubmed: 35340817
J Genet Eng Biotechnol. 2021 Sep 23;19(1):140
pubmed: 34557983
Biomater Res. 2019 Nov 21;23:20
pubmed: 31832232
Biochem Soc Trans. 2016 Dec 15;44(6):1659-1666
pubmed: 27913675
Infect Immun. 2016 Apr 22;84(5):1491-1500
pubmed: 26930703
Res Microbiol. 2010 Sep;161(7):595-603
pubmed: 20600864
Front Chem. 2020 Apr 24;8:286
pubmed: 32391321
BMC Microbiol. 2010 Jun 23;10:179
pubmed: 20573190
J Appl Microbiol. 2023 Feb 16;134(2):
pubmed: 36597783
Infect Drug Resist. 2023 Jan 05;16:19-49
pubmed: 36636380
Arch Razi Inst. 2021 Sep 01;76(3):571-586
pubmed: 34824750
ACS Appl Mater Interfaces. 2020 Mar 25;12(12):13731-13738
pubmed: 32155326
Crit Rev Food Sci Nutr. 2022;62(10):2627-2640
pubmed: 33320702
Materials (Basel). 2023 Mar 10;16(6):
pubmed: 36984102
MedComm (2020). 2023 Apr 04;4(2):e253
pubmed: 37025253
Pathog Glob Health. 2021 Sep;115(6):339-356
pubmed: 33851566
J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1246-1254
pubmed: 34924339
ACS Appl Mater Interfaces. 2021 Sep 8;13(35):41435-41444
pubmed: 34448395
Pharm Res. 2023 Jan;40(1):245-263
pubmed: 36376604
Biotechnol Adv. 2002 Dec;20(5-6):341-59
pubmed: 14550020
Nat Rev Microbiol. 2022 Oct;20(10):621-635
pubmed: 35115704
J Bacteriol. 2013 Oct;195(19):4484-95
pubmed: 23913319
J Microbiol. 2012 Feb;50(1):175-8
pubmed: 22367955
Int Endod J. 2021 Mar;54(3):413-426
pubmed: 33107032
Molecules. 2021 Jun 06;26(11):
pubmed: 34204121
Biomater Sci. 2023 Feb 28;11(5):1648-1664
pubmed: 36723075
Molecules. 2022 Nov 04;27(21):
pubmed: 36364411
J Glob Antimicrob Resist. 2019 Mar;16:36-47
pubmed: 30149193
Microorganisms. 2016 Nov 18;4(4):
pubmed: 27869702
Int J Mol Sci. 2022 Dec 31;24(1):
pubmed: 36614160
Colloids Surf B Biointerfaces. 2014 Apr 1;116:612-9
pubmed: 24262865
Microb Pathog. 2022 Jun;167:105585
pubmed: 35569694
J Food Drug Anal. 2014 Mar;22(1):116-127
pubmed: 24673909
J Biomed Nanotechnol. 2022 Apr 1;18(4):1227-1235
pubmed: 35854440
Biofilm. 2023 Jan 22;5:100105
pubmed: 36711324
Front Mol Biosci. 2019 Aug 06;6:63
pubmed: 31448285
Food Res Int. 2019 May;119:499-509
pubmed: 30884682
Pharmaceutics. 2022 Jun 30;14(7):
pubmed: 35890285
Biochemistry. 2002 Aug 6;41(31):10095-104
pubmed: 12146974
Micromachines (Basel). 2022 Aug 06;13(8):
pubmed: 36014186
Microb Genom. 2016 Dec 12;2(12):e000102
pubmed: 28348840
Inflammation. 2020 Dec;43(6):2344-2356
pubmed: 32948964
Pathogens. 2021 Feb 02;10(2):
pubmed: 33540588
Microorganisms. 2017 Jun 26;5(3):
pubmed: 28672861
J Bacteriol. 2007 Nov;189(22):7945-7
pubmed: 17675377
Curr Pharm Biotechnol. 2022;23(5):664-678
pubmed: 34238148